Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Tongluo Zhitong formula is a traditional Chinese medicine (TCM) herbal formulation developed by the Tianjin Jizhou Traditional Chinese Medicine Hospital for the topical treatment of knee osteoarthritis (KOA). The formula is designed to address synovial hyperplasia, a key pathological feature of the disease, by inhibiting the proliferation of synovial fibroblasts. Research indicates that the formula exerts its therapeutic effects through cell cycle regulation, specifically by inhibiting DNA replication during the S phase and arresting cells in the G2/M phase. This concentration-dependent inhibitory effect helps mitigate joint inflammation and improve function. It is typically administered as an external application, often in combination with physical therapies such as electromagnetic spectrum physiotherapy.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Tongluo Zhitong formula.